Issue #378
- Retroviruses Conference Reassuring on New Treatments, Viral Targets, Research
- Lipoatrophy and Antiretroviral Drug Changes
- Retroviruses Conference: Web Coverage
- d4T and Lactic Acidosis with Neuromuscular Weakness: FDA Warning
- FDA Approves New Dosing for Amprenavir and Ritonavir Combination
- FDA Approves Once-Daily Efavirenz Formulation, Revised Labeling
- AIDS Treatment and Related Conferences, March through December 2002
source: AIDS Treatment News
